2seventy bio, Inc.
TSVT
$4.99
-$0.01-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 482.00K | -19.52M | -9.93M | 24.88M | -52.67M |
| Total Depreciation and Amortization | 1.64M | 1.66M | 1.66M | 1.68M | 2.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.47M | 1.27M | 1.55M | -47.34M | 6.68M |
| Change in Net Operating Assets | -14.57M | 7.13M | -3.78M | -2.36M | 2.01M |
| Cash from Operations | -10.97M | -9.47M | -10.51M | -23.14M | -41.88M |
| Capital Expenditure | -- | 0.00 | -34.00K | -61.00K | -612.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 43.00M | 176.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.63M | 21.99M | -41.46M | 35.50M | 22.27M |
| Cash from Investing | 39.63M | 21.99M | -41.50M | 78.44M | 21.83M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 500.00K | 3.00K | 52.00K | -- | 386.00K |
| Repurchase of Common Stock | -- | -- | -- | -24.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 500.00K | 3.00K | 52.00K | -24.00K | 386.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.15M | 12.52M | -51.95M | 55.27M | -19.66M |